Table 4

Percentage of recovered radioactivity representing intact brimonidine and metabolites 1 h or 15 days after the final dose administrated to cynomolgus monkeys in the multiple 0.5% dose study

Tissues/FluidsTime AfterExtractionBrimonidineMIIIaMIVMV
%
Tear (Schirmer strip)1 h87.4  ± 2.389.8  ± 5.44.4  ± 2.72.6  ± 2.13.2  ± 1.3
15 days78.5  ± 6.1N.A.N.A.N.A.N.A.
Lower bulbar conjunctiva1 h64.8  ± 13.093.8  ± 2.21.3  ± 0.51.6  ± 1.33.4  ± 2.1
15 days40.3  ± 3.391.1  ± 2.72.1  ± 1.12.7  ± 2.24.1  ± 2.3
Upper bulbar conjunctiva1 h82.7  ± 4.295.1  ± 0.51.4  ± 0.61.8  ± 1.11.7  ± 0.9
15 days50.6  ± 3.393.9  ± 1.61.3  ± 0.81.5  ± 1.03.5  ± 1.7
Cornea1 h82.1  ± 8.792.1  ± 1.61.5  ± 0.52.4  ± 0.74.1  ± 0.6
15 days53.1  ± 6.489.8  ± 5.21.6  ± 1.03.3  ± 1.85.4  ± 3.4
Aqueous humor1 h100.0  ± 0.082.7  ± 5.94.9  ± 3.37.0  ± 1.45.4  ± 2.2
15 days100.0  ± 0.0N.A.N.A.N.A.N.A.
Iris1 h92.6  ± 5.696.8  ± 0.50.8  ± 0.50.9  ± 0.41.5  ± 0.6
15 days97.6  ± 0.596.2  ± 0.51.4  ± 0.40.9  ± 0.31.6  ± 0.4
Ciliary body1 h88.8  ± 3.895.5  ± 1.00.5  ± 0.41.2  ± 0.32.9  ± 1.1
15 days92.3  ± 2.397.7  ± 1.70.3  ± 0.30.6  ± 0.51.5  ± 0.9

Results were obtained by HPLC of extracts of ocular tissues and tear samples; data shown are means ± S.D. of values from four eyes (two animals).

  • N.A., data not available; levels of radioactivity were too low for parent and metabolite profiling.